CK-0808

N/A

Report date: 2023/08/01 09:47:00

Base Information

Drug NameCK-0808
Drug Alias NameCK-0808
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionT lymphocyte replacements
TargetsUpdating
Therapy Area/IndicationsLupus Nephritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCellenkos Inc
China Registration ClassN/A

Develop Information

Active CompaniesCellenkos Inc
Inactive CompaniesN/A
Active IndicationsLupus Nephritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A